LSD1抑制剂反苯环丙胺通过p38 MAPK活性对视网膜神经节细胞的潜在神经保护作用
本研究探讨赖氨酸特异性去甲基化酶1(LSD1)抑制剂反苯环丙胺在视网膜神经节细胞(RGC)存活中的作用及神经保护机制。采用原代培养大鼠RGC及NMDA诱导兴奋性毒性的体内模型,发现反苯环丙胺显著抑制谷氨酸神经毒性和氧化应激后的神经元死亡,其保护作用与p38 MAPKγ活性上调相关,且玻璃体内给药可显著挽救体内青光眼模型的RGC数量。
要点
- 反苯环丙胺显著抑制谷氨酸神经毒性和氧化应激诱导的RGC死亡。
- p38 MAPKγ是反苯环丙胺神经保护机制的关键分子。
- 玻璃体内注射反苯环丙胺显著挽救NMDA诱导兴奋性毒性模型的RGC数量。
核心结论
- 反苯环丙胺诱导的转录和表观遗传调控通过促进p38 MAPKγ活性调节RGC存活。
- 抑制LSD1活性的药物治疗可能成为治疗神经退行性疾病的新策略。
研究设计与样本
- 采用原代培养大鼠RGC和体内NMDA诱导兴奋性毒性模型评估反苯环丙胺对神经元存活的作用。
- 通过微阵列和免疫印迹分析评估与反苯环丙胺治疗相关的分子。
主要发现
- 反苯环丙胺显著抑制谷氨酸神经毒性和氧化应激后的神经元细胞死亡。
- 微阵列和免疫印迹分析显示p38 MAPKγ是反苯环丙胺神经保护机制的关键分子,谷氨酸对p38 MAPKγ的显著抑制被反苯环丙胺逆转。
- 药理性抑制总p38 MAPK磷酸化干扰反苯环丙胺的神经保护作用,而特异性抑制p38 MAPKα和p38 MAPKβ不影响RGC存活。
- 玻璃体内给予反苯环丙胺在NMDA诱导兴奋性毒性的体内青光眼模型中显著挽救RGC数量。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The epigenetic mechanisms associated with ocular neurodegenerative diseases remain unclear. The present study aimed to determine the role of lysine-specific demethylase 1 (LSD1), which represses transcription by removing the methyl group from methylated lysine 4 of histone H3, in retinal ganglion cell (RGC) survival, and to investigate the details of the neuroprotective mechanism of tranylcypromine, a major LSD1 inhibitor. METHODS: The authors evaluated whether tranylcypromine contributes to neuronal survival following stress-induced damage using primary cultured rat RGCs and in vivo N-methyl-D-aspartate (NMDA)-induced excitotoxicity. Additionally, the molecules associated with tranylcypromine treatment were assessed by microarray and immunoblot analysis. RESULTS: Tranylcypromine significantly suppressed neuronal cell death following glutamate neurotoxicity and oxidative stress. Microarray and immunoblot analyses revealed that p38 mitogen-activated protein kinase (MAPK)γ was a key molecule involved in the neuroprotective mechanisms induced by tranylcypromine because the significant suppression of p38 MAPKγ by glutamate was reversed by tranylcypromine. Moreover, although pharmacologic inhibition of the phosphorylation of the total p38 MAPKs interfered with neuroprotective effects of tranylcypromine, the specific inhibition of p38 MAPKα and p38 MAPKβ did not influence RGC survival. This suggests that the non-p38 MAPKα/β isoforms have important roles in neuronal survival by tranylcypromine. Additionally, the intravitreal administration of tranylcypromine significantly saved RGC numbers in an in vivo glaucoma model employing NMDA-induced excitotoxicity. CONCLUSIONS: These findings indicate that tranylcypromine-induced transcriptional and epigenetic regulation modulated RGC survival via the promotion of p38 MAPKγ activity. Therefore, pharmacologic treatments that suppress LSD1 activity may be a novel therapeutic strategy that can be used to treat neurodegenerative diseases.
引用
- Tsutsumi T, Iwao K, Hayashi H, et al. Potential Neuroprotective Effects of an LSD1 Inhibitor in Retinal Ganglion Cells via p38 MAPK Activity. Invest Ophthalmol Vis Sci. 2016. PMID: 27893888. doi:10.1167/iovs.16-19494
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。